Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Ascentage Pharma's Novel Drug Olverembatinib Recommended for a Breakthrough Therapy Designation in China for the Treatment of SDH-Deficient GIST, the Second BTD for the Drug 2023-05-31 10:20
Inmagene to Participate in the Jefferies Healthcare Conference on June 8 2023-05-30 20:00
Lunit and the Japan National Cancer Center Hospital East Partner in AI Pathology to Advance Precision Oncology 2023-05-30 20:00
Immorna Announces First Subject Dosed in a Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Vaccine Developed for the Prevention of Shingles 2023-05-30 19:00
iNtRON identifies Prophage and Jamphage in the Pancreatic cancer related Microbiome 2023-05-30 10:15
Bridge Biotherapeutics to Present at the 2023 BIO International Convention 2023-05-30 06:00
CELL WORLD - Aiming at Internationalization, Starting from Regulation - The 1st Global Cell Therapy Summit and Hillgene Biopharma Anniversary Celebration Successfully Held 2023-05-29 20:03
AMP945 Combined with FOLFIRINOX Enhances Treatment Effects in model of Pancreatic Cancer 2023-05-29 16:51
Collaborators at the Keio and Osaka Universities Present Key Non-Clinical Data with Stable/Functional-Induced Regulatory T Cells (S/F-iTregs) in Autoimmune Disease Models 2023-05-29 13:21
Harbour BioMed Reports Results of Phase Ib Clinical Trial of Porustobart in Combination of Toripalimab in Patients with Hepatocellular Carcinoma at ASCO 2023 2023-05-29 09:42
77.4% ORR! Abbisko to present the updated clinical phase Ib data of Pimicotinib (ABSK021) at the 2023 ASCO Annual Meeting 2023-05-28 21:00
Pulse Medical receives FDA Breakthrough Device Designation for its μFR® system 2023-05-26 22:08
ProfoundBio Announces Further Advancement of Lead Programs - PRO1184 (Rinatabart Sesutecan) and PRO1160 in the Clinic 2023-05-26 20:00
FivepHusion Announces Strategic Collaboration with Treehill Partners and Syneos Health 2023-05-26 13:42
Ascentage Pharma Presents Updated Results from Multiple Clinical Studies at American Society of Clinical Oncology Annual Conference 2023-05-26 10:01
Dizal's Oncology Pipeline Continues to Impress with Two Oral Presentations at 2023 ASCO Annual Meeting 2023-05-26 06:00
Daewoong Pharmaceutical Publishes Molecular Mechanism of Bersiporocin as an Antifibrotic in EMBO Molecular Medicine 2023-05-26 06:00
I-Mab Announces Encouraging Phase 1b/2 Study Results of Patients with Advanced NSCLC Receiving Uliledlimab and Toripalimab Combination Therapy at ASCO 2023 2023-05-26 05:01
Lunit Demonstrates Predictive Value of AI-Biomarker Platform at the 2023 ASCO Annual Meeting 2023-05-26 05:00
Hepagene Therapeutics to Present at the European Association for the Study of the Liver (EASL) Congress 2023 2023-05-25 22:00
1 77 78 79 80 81 431